P Juret
About
In The Last Decade
P Juret
22 papers receiving 334 citations
Peers
Comparison fields: 5 of 69
- Molecular Biology 202
- Oncology 173
- Genetics 70
- Cancer Research 61
- Organic Chemistry 54
Countries citing papers authored by P Juret
This map shows the geographic impact of P Juret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Juret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Juret more than expected).
Fields of papers citing papers by P Juret
This network shows the impact of papers produced by P Juret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Juret. The network helps show where P Juret may publish in the future.
Co-authorship network of co-authors of P Juret
This figure shows the co-authorship network connecting the top 25 collaborators of P Juret. A scholar is included among the top collaborators of P Juret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Juret. P Juret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | [Prognostic significance of the thymol test of MacLagan in cancer of the breast. Its paradoxal fluctuations in the course of the development of the disease]. | 1 |
| 2 | 39 | |
| 3 | Toxicité rénale du 9-hydroxy-2-méthyl-ellipticinium. | 1 |
| 4 | [Renal toxicity of 9-hydroxy-2-methyl-ellipticinium]. | 6 |
| 5 | Hydroxy-9-methyl-2-ellipticinium for osseous metastases from breast cancer: a 5-year experience. | 29 |
| 6 | [Hydroxy-9-methyl-2-ellipticinium (NSC 264-137) for osseous metastases from breast cancer. A 4 year experience (author's transl)]. | 2 |
| 7 | [Hydroxy 9-methyl 2-ellipticinium acetate (NSC 264-137). Toxicologic study and therapeutic effect in 100 cancers (author's transl)]. | 9 |
| 8 | 36 | |
| 9 | 69 | |
| 10 | 20 | |
| 11 | 14 | |
| 12 | [New biological evidence on the hormone dependence of breast cancer (preliminary note)]. | 2 |
| 13 | 1 | |
| 14 | [Prognostic value of blood cholesterol in women with cancer of the breast]. | 3 |
| 15 | 2 | |
| 16 | [Decrease of mortality in the rat after administration of lanosterol during an epidemic bronchopulmonary infection]. | 1 |
| 17 | [APROPOS OF 150 IMPLANTATIONS OF INTRA-HYPOPHYSIAL RADIOACTIVE YTTRIUM IN THE TREATMENT OF ADVANCED BREAST CANCER. TECHNIC; CLINICAL RESULTS; INDICATIONS]. | 3 |
| 18 | [Analgesic action of hypophysectomy on the osseous metastases of non-hormone-dependent cancers]. | 1 |
| 19 | [Implantation of intrapituitary radioactive material (Au-198 and Y-90) in metastatic cancers of the breast. Clinical and biological review apropos of 75 cases]. | 1 |
| 20 | [Changes in oxytocic power during pregnancy]. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.